0001104659-24-036286.txt : 20240319
0001104659-24-036286.hdr.sgml : 20240319
20240319195112
ACCESSION NUMBER: 0001104659-24-036286
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240309
FILED AS OF DATE: 20240319
DATE AS OF CHANGE: 20240319
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: STEFANOVICH ROBERT
CENTRAL INDEX KEY: 0001247309
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34632
FILM NUMBER: 24765839
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cryoport, Inc.
CENTRAL INDEX KEY: 0001124524
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 880313393
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 112 WESTWOOD PLACE, SUITE 350
CITY: BRENTWOOD
STATE: TN
ZIP: 37027
BUSINESS PHONE: (949) 232-1900
MAIL ADDRESS:
STREET 1: 112 WESTWOOD PLACE, SUITE 350
CITY: BRENTWOOD
STATE: TN
ZIP: 37027
FORMER COMPANY:
FORMER CONFORMED NAME: CRYOPORT SYSTEMS LLC
DATE OF NAME CHANGE: 20010614
FORMER COMPANY:
FORMER CONFORMED NAME: CRYOPORT SYSTEMS INC
DATE OF NAME CHANGE: 20000923
4
1
tm249281-5_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-03-09
0
0001124524
Cryoport, Inc.
CYRX
0001247309
STEFANOVICH ROBERT
C/O CRYOPORT INC.
112 WESTWOOD PLACE, SUITE 350
BRENTWOOD
TN
37027
0
1
0
0
Chief Financial Officer
0
Common Stock
2024-03-09
4
M
0
2666
0
A
125816
D
Common Stock
2024-03-11
4
S
0
1119
16.3524
D
124697
D
Common Stock
2024-03-15
4
S
0
1035
15.4322
D
123662
D
Common Stock
2024-03-15
4
A
0
5750
0
A
129412
D
Restricted Stock Rights
2024-03-09
4
M
0
2666
0
D
Common Stock
2666
2667
D
Stock Option (right to buy)
16.70
2024-03-15
4
A
0
11500
0
A
2031-03-15
Common Stock
11500
11500
D
Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock.
Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights.
Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning March 15, 2025.
The originally granted restricted stock rights vest in four equal annual installments beginning March 9, 2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2024.
1/48 of options vest on the 15th of each month for forty-eight months beginning April 25, 2024.
/s/ Robert Stefanovich
2024-03-19